Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
7,707,696
-
Shares change
-
+1,377,273
-
Total reported value, excl. options
-
$2,773,941
-
Value change
-
+$508,057
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$0.3600
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q2 2023
14 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q2 2023.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,707,696 shares
of 27,615,000 outstanding shares and own 27.91% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4,553,489 shares), JOHNSON & JOHNSON (2,133,402 shares), MMCAP International Inc. SPC (644,449 shares), RENAISSANCE TECHNOLOGIES LLC (195,495 shares), Virtu Financial LLC (54,033 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (49,500 shares), MILLENNIUM MANAGEMENT LLC (45,850 shares), Walleye Capital LLC (21,056 shares), Walleye Trading LLC (10,422 shares), and UBS Group AG (0 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.